Literature DB >> 9009213

Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation.

M Passalacqua1, A Zicca, B Sparatore, M Patrone, E Melloni, S Pontremoli.   

Abstract

We show here that murine erythroleukemia (MEL) cells, following induction with hexamethylene bisacetamide, accumulate high mobility group (HMG)1 protein onto the external surface of the cell in a membrane-associated form detectable by immunostaining with a specific anti-HMG1 protein antibody. This association is maximal at a time corresponding to cell commitment. At longer times, immunostainable cells are progressively reduced and become almost completely undetectable along with the appearance of hemoglobin molecules. Binding to MEL cells does not affect the native molecular structure of HMG1 protein. The type of functional correlation between HMG1 protein and MEL cell differentiation is suggested by the observation that if an anti-HMG1 protein antibody is added at the same time of the inducer almost complete inhibition of cell differentiation is observed, whereas if the antibody is added within the time period in which cells undergo through irreversible commitment, inhibition progressively disappears. A correlation between MEL cell commitment and the biological effect of HMG1 protein can thus be consistently suggested.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009213     DOI: 10.1016/s0014-5793(96)01402-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

2.  Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation.

Authors:  B Sparatore; M Patrone; M Passalacqua; M Pedrazzi; D Gaggero; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.

Authors:  Hiromasa Takaishi; Takanori Kanai; Atsushi Nakazawa; Fumihiko Sugata; Akira Nikai; Shigeo Yoshizawa; Yasuo Hamamoto; Shinsuke Funakoshi; Tomoharu Yajima; Yasushi Iwao; Masao Takemura; Shoichi Ozaki; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-05-30       Impact factor: 7.527

4.  Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.

Authors:  Bianca Sparatore; Mauro Patrone; Mario Passalacqua; Marco Pedrazzi; Sabina Ledda; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

5.  Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.

Authors:  Sandro Jube; Zeyana S Rivera; Marco E Bianchi; Amy Powers; Ena Wang; Ian Pagano; Harvey I Pass; Giovanni Gaudino; Michele Carbone; Haining Yang
Journal:  Cancer Res       Date:  2012-05-02       Impact factor: 12.701

6.  Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease.

Authors:  A T Linke; B Marchant; P Marsh; G Frampton; J Murphy; M L Rose
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

7.  High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues.

Authors:  Jordana Todorova; Evdokia Pasheva
Journal:  Oncol Lett       Date:  2011-10-24       Impact factor: 2.967

8.  HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration.

Authors:  Rosaria Bassi; Paola Giussani; Viviana Anelli; Thomas Colleoni; Marco Pedrazzi; Mauro Patrone; Paola Viani; Bianca Sparatore; Edon Melloni; Laura Riboni
Journal:  J Neurooncol       Date:  2007-11-02       Impact factor: 4.130

9.  The expression of HMGB1 protein and its receptor RAGE in human malignant tumors.

Authors:  Nora Kostova; Stanislava Zlateva; Iva Ugrinova; Evdokia Pasheva
Journal:  Mol Cell Biochem       Date:  2009-10-30       Impact factor: 3.396

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.